Eversept Partners’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Eversept Partners’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-110,010	Closed	-$4.5M	–	84
2024 Q2	$4.5M	Buy	+110,010	New	+$4.58M	0.31%	45

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Eversept Partners's CERE Position: Q3 2024 in Review

Eversept Partners sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 110,010 shares — an estimated $4.5M sold.

Eversept Partners first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $4.5M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Eversept Partners reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Eversept Partners sold 110,010 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $4.5M.
Eversept Partners first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Eversept Partners's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $4.5M in Q2 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Eversept Partners's 13F filing for Q3 2024, filed 14 Nov 2024.